title: [Psychotropic drugs during pregnancy and lactation: development practice].
abstract: BACKGROUND
  Pregnancy and the postpartum periods are particular for the mother's use of drugs. Therapeutic prescription must take into account the potential risk of fetal malformation, newborn's withdrawal syndrome, feeding type and potential risk of untreated maternal mental illness. Recommendations for good practice are constantly remodeling and their conclusions are sometimes contradictory.
  
  
  METHODS
  The aim of this work is to develop an updated review, easy to use for any professional involved in the monitoring or prescription of a psychotropic medication (antidepressants, anxiolytics-hypnotics, neuroleptics, mood stabilizers and substitution treatment of opioid dependance) for pregnant or nursing women.
  
  
  RESULTS
  These updates in tabular form are also based on our clinical experience as a team specializing in perinatal medicine.
authors.affiliation: CHU de Toulouse, service universitaire de psychiatrie de l'enfant et de l'adolescent, équipe de psychiatrie périnatale de la maternité Paule-de-Viguier, 31059 Toulouse cedex 9, France. Electronic address: bascoul.c@chu-toulouse.fr.
authors.forename: Céline
authors.initials: C
authors.lastname: Bascoul
authors.affiliation: CHU de Toulouse, service universitaire de psychiatrie de l'enfant et de l'adolescent, équipe de psychiatrie périnatale de la maternité Paule-de-Viguier, 31059 Toulouse cedex 9, France.
authors.forename: Ludivine
authors.initials: L
authors.lastname: Franchitto
authors.affiliation: CHU de Toulouse, maternité Paule-de-Viguier, 31059 Toulouse cedex 9, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Parant
authors.affiliation: CHU de Toulouse, hôpital La Grave, service universitaire de psychiatre de l'enfant et de l'adolescent, 31059 Toulouse cedex 9, France.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Raynaud
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology; D001942:Breast Feeding / Q000009:adverse effects; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects; D001523:Mental Disorders / Q000188:drug therapy* / Q000453:epidemiology; D036801:Parturition / Q000187:drug effects; D017410:Practice Guidelines as Topic; D011247:Pregnancy / Q000187:drug effects; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000453:epidemiology; D011619:Psychotropic Drugs / Q000145:classification / Q000627:therapeutic use*
chemical_list: D011619:Psychotropic Drugs